PDGFRA and glioblastoma: We applied our approach to a new genetically engineered mouse model of PDGFRα-driven GBM, and we discovered significant changes in the activity of translational initiation machinery signaling between acutely versus chronically stimulated PDGFRα GBM, which can have therapeutic implications.